Epidemiology and prevention of cutaneous melanoma

Current Treatment Options in Oncology

Volumn 7, Issue 3, 2006, Pages 181-186

  Demierre, Marie France ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUNSCREEN; VITAMIN D;

AGE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RESEARCH; CANCER SCREENING; CANCER SURVIVAL; CAUCASIAN; CHEMOPROPHYLAXIS; CLINICAL FEATURE; GEOGRAPHIC DISTRIBUTION; HEALTH EDUCATION; HUMAN; MEDICAL EDUCATION; MELANOMA; PROTECTIVE CLOTHING; RADIATION PROTECTION; REVIEW; RISK FACTOR; SEX DIFFERENCE; SKIN CANCER; SKIN PIGMENTATION; SUNBURN; SUNLIGHT; VITAMIN SUPPLEMENTATION;

HUMANS; MELANOMA; SKIN NEOPLASMS;

EID: 33646244275     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-006-0011-z     Document Type: Review

References (51)

1. Lens MB, Dawes M: Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 2004, 150:179-185.
2. Jhappan C, Noonan FP, Merlino G: Ultraviolet radiation and cutaneous malignant melanoma. Oncogene 2003, 22:3099-3112.
3. Nelemans PJ, Groenendal H, Kiemeney LA: Effect of intermittent exposure to sunlight on melanoma risk among indoor workers and sun-sensitive individuals. Environ Health Perspect 1993, 101:252.
4. Elwood JM, Gallagher RP, Hill GB, Pearson JC: Cutaneous melanoma in relation to intermittent and constant sun exposure-The Western Canada Melanoma Study. Int J Cancer 1985, 35:427.
5. Armstrong BK, Kricker A: How much melanoma is caused by sun exposure? Melanoma Res 1993, 3:395-401.
6. Tucker MA, Goldstein AM: Melanoma etiology: where are we? Oncogene 2003, 22:3042-3052.
7. van der Velden PA, Sandkuijl LA, Bergman W, et al.: Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 2001, 69:774-779.
8. Whiteman DC, Watt P, Purdie DM, et al.: Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 2003, 95:806-812.
9. Curtin JA, Fridlyand J, Kageshita T, et al.: Distinct sets of genetic alterations in melanoma. N Engl J Med 2005, 353:2135-2147.
10. Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. CA Cancer J Clin 2005, 55:10-30.
11. Geller AC, Miller DR. Annas GD, et al.: Melanoma incidence and mortality among US whites, 1969-1999. JAMA 2002, 288:1719-1720.
12. Jemal A, Devesa SS, Hartge P, Tucker MA: Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001, 93:678-683.
13. Demierre MF, Chung C, Miller DR, Geller AC: Early detection of thick melanomas in the US? "Beware" of the nodular subtype. Arch Dermatol 2005, 141:745-750.
14. Chamberlain AJ, Fritschi L, Giles GG, et al.: Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol 2002, 138:609-614.
15. Bergenmar M, Ringborg U, Mansson Brahme E, Brandberg Y: Nodular histogenetic type-the most significant factor for thick melanoma: implications for prevention. Melanoma Res 1998, 8:403-411.
16. Crocetti E, Carli P: Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. Eur J Dermatol 2003, 13:72-75.
17. Swetter SM, Boldrick JC, Jung SY, et al.: Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol 2005, 125:685-691.
18. MacKie R: Melanoma incidence in the west of Scotland over 25 years. Proceedings of the 6th World Congress on Melanoma. Vancouver, Canada, September 6-10 2005.
19. de Vries E, Bray FI, Coebergh JW; Parkin DM: Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003, 107:119-126.
20. de Vries E, Schouten LJ, Visser O, et al.: Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer 2003, 39:1439-1446.
21. Edwards BK, Brown ML, Wingo PA, et al.: Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005, 97:1407-1427.
22. deVries E, Bray FI, Coebeergh JWW, Parkin DM: Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in Scandinavia. Int J Cancer 2003, 107:119-126.
23. Bosetti C, La Vecchia C, Naldi L, et al.: Mortality from cutaneous malignant melanoma in Europe. Has the epidemic leveled off? Melanoma Res 2004, 14:301-309.
24. Cayuela A, Rodriguez-Dominguez S, Lapetra-Peralta J, Conejo-Mir JS: Has mortality from malignant melanoma stopped rising in Spain? Analysis of trends between 1975 and 2001. Br J Dermatol 2005, 152:997-1000.
25. Geller AC, Sober AJ, Zhang Z, et al.: Strategies for improving melanoma education and screening for men age > or = 50 years: findings from the American Academy of Dermatological National Skin Cancer Screening Program. Cancer 2002, 95:1554-1561.
26. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS: Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000, 143:513-519.
27. Hollenbeak CS, Todd MM, Billingsley EM, et al.: Increased incidence of melanoma in renal transplantation recipients. Cancer 2005, 104:1962-1967.
28. Strouse JJ, Fears TR, Tucker MA, Wayne AS: Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 2005, 23:4735-4741.
29. Hu S, Ma F, Collado-Mesa F, Kirsner RS: UV radiation, latitude, and melanoma in US Hispanics and blacks. Arch Darmatol 2004, 140:819-824.
30. Eide MJ, Weinstock MA: Association of UV index, latitude, and melanoma incidence in nonwhite populations - US Surveillance, Epidemiology, and End Results (SEER) Program, 1992-2001. Arch Dermatol 2005, 141:477-481.
31. Berwick M, Armstrong BK, Ben-Porat L, et al.: Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005, 97:195-199.
32. Webb AR, DeCosta BR, Holick MF: Sunlight regulates the cutaneous production of vitamin D3 by causing its photodegradation. J Clin Endocrinol Metab 1989, 68:882-887.
33. Egan KM, Sosman JA, Blot WJ: Sunlight and reduced risk of cancer: is the real story vitamin D? J Natl Cancer Inst 2005, 97:161-163.
34. Lim HW, Gilchrest BA, Cooper KD, et al.: Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol 2005, 52:868-876.
35. Rhodes AR: Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? Cancer 1995, 75:613.
36. Godar DE, Urback F, Gasparro FP, van der Leun JC: UV doses of young adults. Photochem Photobiol 2003, 77:453-457.
37. Robinson JK, Rigel DS, Amonette RA: Trends in sun exposure knowledge, attitudes, and behaviors: 1986 to 1996. J Am Acad Dermatol 1997, 37:179-186.
38. Benjes LS, Brooks DR, Zhang Z, et al.: Changing patterns of sun protection between the first and second summers for very young children. Arch Dermatol 2004, 140:925-930.
39. McGuire-Eisen M, Rothman K, Demierre MF: The ABCs of sun protection for children. Dermatol Nurs 2006, In press.
40. Gallagher RP, Rivers JK, Lee TK, et al.: Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial. JAMA 2000, 283:2955-2960.
41. Diffey BL: Sunscreens and melanoma: the future looks bright. Br J Dermatol 2005, 153:378-381.
42. Mahler HI, Kulik JA, Harrell J, et al.: Effects of UV photographs, photoaging information, and use of sunless tanning lotion on sun protection behaviors. Arch Dermatol 2005, 141:373-380.
43. Lindholm C, Andersson R, Dufmats M, et al.: Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors. Cancer 2004, 101:2067-2078.
44. Institute of Medicine: Extending Medicare Coverage for Prevention and Other Services. Washington DC: National Academy Press; 2000.
45. Abbasi NR, Shaw HM, Rigel DS, et al.: Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA 2004, 292:2771-2776.
46. Demierre MF, Nathanson L: Chemoprevention of melanoma: an unexplored strategy. J Clin Oncol 2003, 21:158-165.
47. Edwards BK, Howe HL, Ries LA, et al.: Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002, 94:2766-2792.
48. Lippman SM, Hong WK: Cancer prevention science and practice. Cancer Res 2002, 62:5119-5125.
49. Demierre MF, Sondak VK: Cutaneous melanoma: pathogenesis and rationale for chemoprevention. Crit Rev Oncol Hematol 2005, 53:225-239.
50. Demierre MF, Lippman SM, Higgins P, Gruber S: Statins and cancer prevention. Nat Rev Cancer 2005, 5:930-942.
51. Demierre MF, Sondak VK: Chemoprevention of melanoma: theoretical and practical considerations. Cancer Control J 2005, 12:219-222.